G01N 2333/00
Assays involving biological materials from specific organisms or of a specific nature
G01N2333/00 (Assays involving biological materials from specific organisms or of a specific nature) appears on 21,291 US grants and 37,089 published applications in this corpus.
Search patents in G01N- Granted patents
- 21,291
- Published applications
- 37,089
- Assignees
- 10,353
- Inventors
- 65,181
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 14 | 0 |
| 1978 | 15 | 0 |
| 1979 | 18 | 0 |
| 1980 | 17 | 0 |
| 1981 | 30 | 0 |
| 1982 | 25 | 0 |
| 1983 | 24 | 0 |
| 1984 | 31 | 0 |
| 1985 | 16 | 0 |
| 1986 | 33 | 0 |
| 1987 | 35 | 0 |
| 1988 | 37 | 0 |
| 1989 | 38 | 0 |
| 1990 | 44 | 0 |
| 1991 | 35 | 0 |
| 1992 | 69 | 0 |
| 1993 | 86 | 0 |
| 1994 | 95 | 0 |
| 1995 | 102 | 0 |
| 1996 | 125 | 0 |
| 1997 | 216 | 0 |
| 1998 | 373 | 0 |
| 1999 | 377 | 0 |
| 2000 | 338 | 0 |
| 2001 | 352 | 119 |
| 2002 | 368 | 621 |
| 2003 | 339 | 1089 |
| 2004 | 309 | 882 |
| 2005 | 294 | 1014 |
| 2006 | 399 | 1013 |
| 2007 | 373 | 1059 |
| 2008 | 432 | 1011 |
| 2009 | 463 | 1351 |
| 2010 | 674 | 1539 |
| 2011 | 667 | 1459 |
| 2012 | 684 | 1404 |
| 2013 | 767 | 1432 |
| 2014 | 871 | 1542 |
| 2015 | 1033 | 2297 |
| 2016 | 1086 | 2376 |
| 2017 | 1228 | 2097 |
| 2018 | 1291 | 1879 |
| 2019 | 1322 | 1673 |
| 2020 | 1284 | 1672 |
| 2021 | 1032 | 1718 |
| 2022 | 860 | 1653 |
| 2023 | 751 | 1616 |
| 2024 | 790 | 1745 |
| 2025 | 828 | 1665 |
| 2026 | 587 | 1163 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2333/435From animalsIndexing code11,878
- G01N 2333/90EnzymesIndexing code6,400
- G01N 2333/005From virusesIndexing code2,372
- G01N 2333/195From bacteriaIndexing code2,105
- G01N 2333/81Protease inhibitorsIndexing code469
- G01N 2333/37From fungiIndexing code326
- G01N 2333/795Porphyrin- or corrin-ring-containing peptidesIndexing code201
- G01N 2333/415From plantsIndexing code180
All 13 subgroupsShow fewer
Recent patents
- Compositions, methods and kits for treating complement related disorders6 Oct 2026US 12,751,993 B2Trustees of Tufts College
- Anti-ABCG2 antibodies and uses thereof6 Oct 2026US 12,753,241 B2William Robert Arathoon Living Trust Dated August 29, 2016
- Monoclonal antibody used for diagnosis and early onset of prostate cancer6 Oct 2026US 12,753,244 B2Taipei Medical University
- Identifying and classifying microorganisms6 Oct 2026US 12,753,428 B2Board of Regents, The University of Texas System
- Integrated method for urinary prostate specific Antigen N-glycosylation profiling by capillary electrophoresis6 Oct 2026US 12,754,163 B2Pannon Egyetem
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Composition, methods and uses8 Oct 2026US 2026/0306509 A14E Therapeutics, Inc.
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Anti-cmet antibody, antibody-drug conjugate, and preparation method therefor and use thereof8 Oct 2026US 2026/0306651 A1MediLink Therapeutics (Suzhou) Co., Ltd.
- Method for isolating fetuin-a8 Oct 2026US 2026/0308213 A1PreviPharma GmbH
Most cited
By later US patents
- Method of using a small volume in vitro analyte sensor1,793US 6,120,676 ATheraSense, Inc. · 2000
- Small volume in vitro analyte sensor1,656US 6,143,164 AE. Heller & Company · 2000
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Small volume in vitro analyte sensor1,028US 6,551,494 B1TheraSense, Inc. · 2003
- Small volume in vitro analyte sensor1,023US 6,576,101 B1TheraSense, Inc. · 2003